Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Revenues
Product	$ 17,902,512	$ 9,556,590	$ 48,770,419	$ 29,094,208
Total revenue	17,902,512	9,556,590	48,770,419	29,094,208
Cost of revenue	5,311,565	2,801,571	14,493,321	8,600,194
Gross profit	12,590,947	6,755,019	34,277,098	20,494,014
Operating expenses:
Selling expenses	11,609,943	4,414,710	28,611,090	13,950,357
General and administrative expenses	4,463,467	2,512,510	13,820,989	8,043,078
Research and development expenses	1,842,837	1,426,483	3,701,697	3,570,468
Total operating expenses	17,916,247	8,353,703	46,133,776	25,563,903
Loss from operations	(5,325,300)	(1,598,684)	(11,856,678)	(5,069,889)
Other income (expense):
Interest income	37,785	22,653	61,954	59,708
Interest expense	(755,528)		(1,624,659)
Other	(434)	(13,650)	(1,578)	(30,817)
Total other income (expense)	(718,177)	9,003	(1,564,283)	28,891
Loss from operations before income taxes	(6,043,477)	(1,589,681)	(13,420,961)	(5,040,998)
Income tax benefit	455,000		4,540,000
Net loss	$ (5,588,477)	$ (1,589,681)	$ (8,880,961)	$ (5,040,998)
Net loss per share:
Basic	$ (0.34)	$ (0.17)	$ (0.64)	$ (0.55)
Diluted	$ (0.34)	$ (0.17)	$ (0.64)	$ (0.55)
Weighted average shares - Basic	16,619,981	9,390,665	13,841,032	9,245,879
Weighted average shares - Diluted	16,619,981	9,390,665	13,841,032	9,245,879